1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer (
- 2020
- Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer : Subgroup analysis of ARTSCAN-trial (
- 2019
- Basic concepts and applications of functional magnetic resonance imaging for radiotherapy of prostate cancer (
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial (
- 2018
- MR and CT data with multiobserver delineations of organs in the pelvic area-Part of the Gold Atlas project (
- 2017
- Dysphagia - Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial (
- MR-OPERA : A Multicenter/Multivendor Validation of Magnetic Resonance Imaging-Only Prostate Treatment Planning Using Synthetic Computed Tomography Images (
- Role of radiotherapy fractionation in head and neck cancers (MARCH) : an updated meta-analysis (
- 2016
- Aspiration as a late complication after accelerated versus conventional radiotherapy in patients with head and neck cancer. (
- Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up. (